International Business Watch
SEE OTHER BRANDS

Get your business and economy news from the world

Crazy or genius? CEO of OpenAI, Musk seek to imbed AI into human body

(MENAFN) U.S. billionaires and tech leaders Sam Altman, CEO of OpenAI, and Elon Musk, founder of Tesla, are spearheading efforts to integrate artificial intelligence and biotechnology directly into the human body. A philosophy professor cautioned that without strong ethical protections, such ventures could risk "dehumanization."

Reports suggest Altman is preparing to launch Merge Labs, a brain–computer interface company positioned to rival Musk’s Neuralink.

Ahmet Dag, a professor at Bursa Uludag University in Türkiye, explained that the core ambition of these projects is to push beyond human biological boundaries, enhancing mental, physical, and psychological functions.

He pointed out that discussions around this idea, often referred to as “transhumanism,” were brought into mainstream debate years earlier by futurist Ray Kurzweil, long before Musk and Altman began pursuing it.

“Technological singularity, which came to the fore with Musk’s Neuralink in 2021, seeks to transfer human consciousness to machines through brain–computer interfaces and implants,” Dag said. “Sam Altman’s involvement in this new initiative shows that this tech is going to transform health care and education, but it will also bring about global economic and social shifts.”

MENAFN23082025000045017281ID1109966297

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions